Daniel Comiskey to Polymorphism, Single Nucleotide
This is a "connection" page, showing publications Daniel Comiskey has written about Polymorphism, Single Nucleotide.
Connection Strength
0.409
-
Truong T, Lesueur F, Sugier PE, Guibon J, Xhaard C, Karimi M, Kulkarni O, Lucotte EA, Bacq-Daian D, Boland-Auge A, Mulot C, Laurent-Puig P, Schvartz C, Guizard AV, Ren Y, Adjadj E, Rach?di F, Borson-Chazot F, Ortiz RM, Lence-Anta JJ, Pereda CM, Comiskey DF, He H, Liyanarachchi S, de la Chapelle A, Elisei R, Gemignani F, Thomsen H, Forsti A, Herzig AF, Leutenegger AL, Rubino C, Ostroumova E, Kesminiene A, Boutron-Ruault MC, Deleuze JF, Gu?nel P, de Vathaire F. Multiethnic genome-wide association study of differentiated thyroid cancer in the EPITHYR consortium. Int J Cancer. 2021 06 15; 148(12):2935-2946.
Score: 0.146
-
Comiskey DF, He H, Liyanarachchi S, Sheikh MS, Genutis LK, Hendrickson IV, Yu L, Brock PL, de la Chapelle A. Variants in LRRC34 reveal distinct mechanisms for predisposition to papillary thyroid carcinoma. J Med Genet. 2020 08; 57(8):519-527.
Score: 0.136
-
Jendrzejewski JP, Sworczak K, Comiskey DF, de la Chapelle A. Clinical implications of GWAS variants associated with differentiated thyroid cancer. Endokrynol Pol. 2019; 70(5):423-429.
Score: 0.126